Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

0566 Impact of Obstructive Sleep Apnea in Patient Admitted For Diabetic Ketoacidosis. Analysis Of The National Inpatient Sample

View through CrossRef
Abstract Introduction The prevalence of type 2 diabetes mellitus in patients with obstructive sleep apnea has been estimated to be 15-30%. Studies have shown increased severity of diabetes in patients with underlying OSA independent of other confounders such as age and obesity.We aim to assess the effect of obstructive sleep apnea on patients admitted for diabetic ketoacidosis. Methods We queried the National Inpatient Sample (NIS) 2016, 2017, and 2018. We searched the NIS for adult patients hospitalized with DKA as principal diagnosis with exposure of OSA as a secondary diagnosis using ICD-10 codes. The primary outcome was inpatient mortality, while secondary outcomes were length of stay (LOS), total hospital charge, cerebral edema, cardiac arrest, acute respiratory failure (ARF), and health cost utilization defined by total hospitalization costs. Multivariable logistic and linear regression analysis was applied to estimate the clinical outcomes. STATA software was used to analyze the data. Results There were about 367,555 adult hospitalizations principally for DKA, of which 2.5% had OSA as a secondary diagnosis. Demographic characteristics based on OSA vs non-OSA cohorts with mean age of 52.3 years (CI 51.6-52.9) vs 40.4 years (CI 40.2-40.5), females (43.2% vs 49.7%), Whites (64.7% vs 57.2%), Black (25.6% vs 26.7%), and Hispanic (7.1% vs 11.6%). A total of 1,440 inpatient mortality (0.39%) occurred in hospitalizations for DKA. After adjusting for age, sex, disease severity and race, hospitalizations for DKA with OSA had similar inpatient mortality [0.59% vs 0.39%, AOR 0.81, 95% CI: 0.423 - 1.565, p=0.538], total hospital charge [$38,790 vs $30,516 P=0.185], LOS [4.19 vs 3.27 days, P=0.064], cerebral edema [0.32% vs 0.1% AOR 1.25, 95% CI: 0.437 - 3.616, p=0.671], cardiac arrest [0.54% vs 0.27% AOR 1.01, 95% CI: 0.493 - 2.105, p=0.959] compared to those without DM. However patient with OSA had an increased odds of ARF [0.55% vs 0.22% AOR 1.48, 95% CI: 1.173 - 1.867, p=0.001]. Conclusion In conclusion, patients admitted primarily for DKA with co-existing OSA had similar inpatient mortality, LOS, total hospital charges, cerebral edema, and cardiac arrest compared to those without OSA. However, the OSA group had more odds of ARF. Support (If Any) 1. Reutrakul S, Mokhlesi B. Obstructive Sleep Apnea and Diabetes: A State of the Art Review. Chest. 2017;152(5):1070-1086. doi:10.1016/j.chest.2017.05.0092. Mahmood K, Akhter N, Eldeirawi K, et al. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med. 2009;5(3):215-221.3. Morgenstern M, Wang J, Beatty N, Batemarco T, Sica AAL, Greenberg H. Obstructive sleep apnea: an unexpected cause of insulin resistance and diabetes. Endocrinol Metab Clin North Am 2014;43:187–204
Title: 0566 Impact of Obstructive Sleep Apnea in Patient Admitted For Diabetic Ketoacidosis. Analysis Of The National Inpatient Sample
Description:
Abstract Introduction The prevalence of type 2 diabetes mellitus in patients with obstructive sleep apnea has been estimated to be 15-30%.
Studies have shown increased severity of diabetes in patients with underlying OSA independent of other confounders such as age and obesity.
We aim to assess the effect of obstructive sleep apnea on patients admitted for diabetic ketoacidosis.
Methods We queried the National Inpatient Sample (NIS) 2016, 2017, and 2018.
We searched the NIS for adult patients hospitalized with DKA as principal diagnosis with exposure of OSA as a secondary diagnosis using ICD-10 codes.
The primary outcome was inpatient mortality, while secondary outcomes were length of stay (LOS), total hospital charge, cerebral edema, cardiac arrest, acute respiratory failure (ARF), and health cost utilization defined by total hospitalization costs.
Multivariable logistic and linear regression analysis was applied to estimate the clinical outcomes.
STATA software was used to analyze the data.
Results There were about 367,555 adult hospitalizations principally for DKA, of which 2.
5% had OSA as a secondary diagnosis.
Demographic characteristics based on OSA vs non-OSA cohorts with mean age of 52.
3 years (CI 51.
6-52.
9) vs 40.
4 years (CI 40.
2-40.
5), females (43.
2% vs 49.
7%), Whites (64.
7% vs 57.
2%), Black (25.
6% vs 26.
7%), and Hispanic (7.
1% vs 11.
6%).
A total of 1,440 inpatient mortality (0.
39%) occurred in hospitalizations for DKA.
After adjusting for age, sex, disease severity and race, hospitalizations for DKA with OSA had similar inpatient mortality [0.
59% vs 0.
39%, AOR 0.
81, 95% CI: 0.
423 - 1.
565, p=0.
538], total hospital charge [$38,790 vs $30,516 P=0.
185], LOS [4.
19 vs 3.
27 days, P=0.
064], cerebral edema [0.
32% vs 0.
1% AOR 1.
25, 95% CI: 0.
437 - 3.
616, p=0.
671], cardiac arrest [0.
54% vs 0.
27% AOR 1.
01, 95% CI: 0.
493 - 2.
105, p=0.
959] compared to those without DM.
However patient with OSA had an increased odds of ARF [0.
55% vs 0.
22% AOR 1.
48, 95% CI: 1.
173 - 1.
867, p=0.
001].
Conclusion In conclusion, patients admitted primarily for DKA with co-existing OSA had similar inpatient mortality, LOS, total hospital charges, cerebral edema, and cardiac arrest compared to those without OSA.
However, the OSA group had more odds of ARF.
Support (If Any) 1.
Reutrakul S, Mokhlesi B.
Obstructive Sleep Apnea and Diabetes: A State of the Art Review.
Chest.
2017;152(5):1070-1086.
doi:10.
1016/j.
chest.
2017.
05.
0092.
Mahmood K, Akhter N, Eldeirawi K, et al.
Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample.
J Clin Sleep Med.
2009;5(3):215-221.
3.
Morgenstern M, Wang J, Beatty N, Batemarco T, Sica AAL, Greenberg H.
Obstructive sleep apnea: an unexpected cause of insulin resistance and diabetes.
Endocrinol Metab Clin North Am 2014;43:187–204.

Related Results

0864 Severe Central Sleep Apnea
0864 Severe Central Sleep Apnea
Abstract Introduction Central sleep apnea (CSA) is a rare form of sleep disordered breathing with repeated apneic episodes with ...
Clinical Study on the Ocular Manifestations in Patients with Obstructive Sleep Apnea Syndrome—Preliminary Results
Clinical Study on the Ocular Manifestations in Patients with Obstructive Sleep Apnea Syndrome—Preliminary Results
Obstructive sleep apnea syndrome is a multisystemic disorder associated with a series of side effects. Obstructive sleep apnea syndrome (OSAS) includes hypoxemia and is correlated ...
High prevalence of obstructive sleep apnea in Marfan's syndrome
High prevalence of obstructive sleep apnea in Marfan's syndrome
Objective To review the current evidence about the prevalence of obstructive sleep apnea in patients with Marfan's syndrome, and discuss some proposed potential mechani...
1027 Valproic Acid and Central Sleep Apnea: A Retrospective Study
1027 Valproic Acid and Central Sleep Apnea: A Retrospective Study
Abstract Introduction Central sleep apnea (CSA) is associated with several medical conditions (e.g., heart failure, atrial fibri...
Advanced oxidation protein products and ischaemia‐modified albumin in obstructive sleep apnea
Advanced oxidation protein products and ischaemia‐modified albumin in obstructive sleep apnea
AbstractBackgroundSeveral studies have shown that obstructive sleep apnea increases incidence of cardiovascular morbidity and mortality. The high systemic oxidative stress in obstr...
Acupuncture as therapeutic resource in patient with bruxism
Acupuncture as therapeutic resource in patient with bruxism
Bruxism is the harmful habit of clenching or grinding the teeth during the day and / or night, with unconscious pattern, with particular intensity and frequency, outside the functi...
The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance
The relationship between sleep and glucagon‐like peptide 1 in patients with abnormal glucose tolerance
SummaryGlucagon‐like peptide 1 plays a role in glucose regulation. Sleep disturbances (obstructive sleep apnea, insufficient or poor sleep quality) have been shown to adversely aff...

Back to Top